GATA-3 immunostaining frequency was equivalent to that of ER: the degree of GATA-3 expression in tumors well differentiated was significantly higher in the group of benign tumors and well-differentiated carcinomas, while its expression was lower in aggressive tumors (p < 0.05) (Figure 2 and Table 2). This evidence concerns the gene GATA3 and benign neoplasm.